Using Biomarkers to Predict TB Treatment Duration

NCT02821832 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

946

Enrollment

NIH

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

PROCEDURE: Saliva collection
PROCEDURE: Urine collection
PROCEDURE: Sputum collection
PROCEDURE: Blood Collection
RADIATION: PET/CT Scan
DRUG: Isoniazid, Rifampicin, Pyrazinamide and Ethambutol

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)